Skip to main content

Table 4 Reporting quality metrics for seven primary results papers

From: Bayesian statistics in the design and analysis of cluster randomised controlled trials and their reporting quality: a methodological systematic review

Reporting quality criteria N (%)

Total (N = 7)

Year of publication

Journal endorsement of

CONSORT guidelines

Statistician involvement

2012 or earlier (N = 4)

2013 onwards (N = 3)

High/medium (N = 4)

Low/none (N = 3)

Yes (N = 5)

No (N = 2)

Description of sample size method

4 (57.1)

2 (50.0)

2 (66.7)

2 (50.0)

2 (66.7)

2 (40.0)

2 (100.0)

 Was clustering clearly accounted for in sample size calculation

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Specification of the required number of clusters

2 (50.0)

1 (50.0)

1 (50.0)

1 (50.0)

1 (50.0)

1 (50.0)

1 (50.0)

 Specification of the assumed cluster size

2 (50.0)

1 (50.0)

1 (50.0)

1 (50.0)

1 (50.0)

1 (50.0)

1 (50.0)

 Specification of whether equal or unequal cluster sizes are assumed

1 (25.0)

1 (50.0)

0 (0.0)

0 (0.0)

1 (50.0)

0 (0.0)

1 (50.0)

 Variability in cluster size accounted for

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Specification of the ICC used for the sample size

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 Indication of the uncertainty of the ICC

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 Accounted for the uncertainty in the ICC

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Other CONSORT metrics

 Details of how clustering was accounted for in the analysis

6 (85.7)

4 (100.0)

2 (66.7)

4 (100.0)

2 (66.7)

5 (100.0)

1 (50.0)

 Specification of the number of clusters randomised

7 (100.0)

4 (100.0)

3 (100.0)

4 (100.0)

3 (100.0)

5 (100.0)

2 (100.0)

 Specification of the number of clusters receiving intended treatment

  Explicit

5 (71.4)

3 (75.0)

2 (66.7)

4 (100.0)

1 (33.3)

4 (80.0)

1 (50.0)

  Implied

2 (28.6)

1 (25.0)

1 (33.3)

0 (0.0)

2 (66.7)

1 (20.0)

1 (50.0)

 Specification of the number of clusters analysed for the primary outcome at the primary endpoint

  Explicit

2 (28.6)

1 (25.0)

1 (33.3)

2 (50.0)

0 (0.0)

2 (40.0)

0 (0.0)

  Implied

5 (71.4)

3 (75.0)

2 (66.7)

2 (50.0)

3 (100.0)

3 (60.0)

2 (100.0)

 Details of cluster-level losses and exclusions

  Explicit

3 (42.9)

2 (50.0)

1 (33.3)

2 (50.0)

1 (33.3)

2 (40.0)

1 (50.0)

  Implied

4 (57.1)

2 (50.0)

2 (66.7)

2 (50.0)

2 (66.7)

3 (60.0)

1 (50.0)

 Details of individual-level losses and exclusions

4 (57.1)

2 (50.0)

2 (66.7)

2 (50.0)

2 (66.7)

2 (40.0)

2 (100.0)

 Individual-level baseline characteristics presented

7 (100.0)

4 (100.0)

3 (100.0)

4 (100.0)

3 (100.0)

5 (100.0)

2 (100.0)

 Cluster-level baseline characteristics presented

2 (28.6)

2 (50.0)

0 (0.0)

1 (25.0)

1 (33.3)

1 (20.0)

1 (50.0)

Coefficients of intracluster correlation provided for primary outcomes

All

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Some

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Coefficients of intracluster correlation provided for secondary outcomes

All

0 (0.0)a

0 (0.0)

0 (0.0)a

0 (0.0)

0 (0.0)a

0 (0.0)

0 (0.0)a

Some

0 (0.0)a

0 (0.0)

0 (0.0)a

0 (0.0)

0 (0.0)a

0 (0.0)

0 (0.0)a

P-values provided for baseline comparisons

5 (71.4)

3 (75.0)

2 (66.7)

3 (75.0)

2 (66.7)

3 (60.0)

2 (100.0)

Clustering accounted for in the calculation of the p-values

Yes

1 (20.0)

1 (33.3)

0 (0.0)

1 (33.3)

0 (0.0)

1 (33.3)

0 (0.0)

Unclear

1 (20.0)

1 (33.3)

0 (0.0)

1 (33.3)

0 (0.0)

1 (33.3)

0 (0.0)

  1. aOne study did not have any secondary outcomes